CSL Future Growth
Future criteria checks 3/6
CSL is forecast to grow earnings and revenue by 13% and 6.5% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 18.6% in 3 years.
Key information
13.0%
Earnings growth rate
13.0%
EPS growth rate
Biotechs earnings growth | 15.6% |
Revenue growth rate | 6.5% |
Future return on equity | 18.6% |
Analyst coverage | Good |
Last updated | 18 Dec 2024 |
Recent future growth updates
Recent updates
With EPS Growth And More, CSL (ASX:CSL) Makes An Interesting Case
Nov 01We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt
Oct 05CSL (ASX:CSL) Gains Approval for Updated COVID-19 Vaccine in Japan, Boosting Strategic Alliances
Sep 18Getting In Cheap On CSL Limited (ASX:CSL) Is Unlikely
Sep 03CSL Limited (ASX:CSL) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 16An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 27% Undervalued
Aug 07CSL Limited's (ASX:CSL) Price Is Out Of Tune With Earnings
May 22An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 20% Undervalued
May 01Does CSL (ASX:CSL) Have A Healthy Balance Sheet?
Mar 19CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors
Feb 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 17,989 | 4,132 | 4,076 | 4,949 | 14 |
6/30/2026 | 16,838 | 3,626 | 3,619 | 4,364 | 15 |
6/30/2025 | 15,745 | 3,093 | 3,005 | 3,808 | 15 |
6/30/2024 | 14,800 | 2,642 | 1,506 | 2,764 | N/A |
3/31/2024 | 14,490 | 2,557 | 1,332 | 2,727 | N/A |
12/31/2023 | 14,179 | 2,472 | 1,158 | 2,690 | N/A |
9/30/2023 | 13,745 | 2,333 | 1,034 | 2,646 | N/A |
6/30/2023 | 13,310 | 2,194 | 909 | 2,601 | N/A |
3/31/2023 | 12,507 | 2,156 | 765 | 2,392 | N/A |
12/31/2022 | 11,705 | 2,118 | 622 | 2,182 | N/A |
9/30/2022 | 11,133 | 2,186 | 1,001 | 2,406 | N/A |
6/30/2022 | 10,562 | 2,255 | 1,381 | 2,629 | N/A |
3/31/2022 | 10,587 | 2,290 | 1,251 | 2,679 | N/A |
12/31/2021 | 10,612 | 2,325 | 1,121 | 2,728 | N/A |
9/30/2021 | 10,461 | 2,350 | 1,538 | 3,175 | N/A |
6/30/2021 | 10,310 | 2,375 | 1,955 | 3,622 | N/A |
3/31/2021 | 10,145 | 2,520 | 2,127 | 3,597 | N/A |
12/31/2020 | 9,980 | 2,665 | 2,299 | 3,571 | N/A |
9/30/2020 | 9,565 | 2,384 | 1,710 | 3,030 | N/A |
6/30/2020 | 9,151 | 2,103 | 1,121 | 2,488 | N/A |
3/31/2020 | 9,048 | 2,054 | 1,009 | 2,418 | N/A |
12/31/2019 | 8,944 | 2,006 | 897 | 2,347 | N/A |
9/30/2019 | 8,742 | 1,962 | 628 | 1,996 | N/A |
6/30/2019 | 8,539 | 1,919 | 360 | 1,644 | N/A |
3/31/2019 | 8,406 | 1,861 | 426 | 1,621 | N/A |
12/31/2018 | 8,274 | 1,803 | 492 | 1,597 | N/A |
9/30/2018 | 8,094 | 1,766 | 701 | 1,750 | N/A |
6/30/2018 | 7,915 | 1,729 | 910 | 1,902 | N/A |
3/31/2018 | 7,666 | 1,674 | N/A | 1,662 | N/A |
12/31/2017 | 7,417 | 1,618 | N/A | 1,422 | N/A |
9/30/2017 | 7,182 | 1,478 | N/A | 1,335 | N/A |
6/30/2017 | 6,947 | 1,337 | N/A | 1,247 | N/A |
3/31/2017 | 6,802 | 1,333 | N/A | 1,192 | N/A |
12/31/2016 | 6,656 | 1,329 | N/A | 1,138 | N/A |
9/30/2016 | 6,386 | 1,286 | N/A | 1,158 | N/A |
6/30/2016 | 6,115 | 1,242 | N/A | 1,179 | N/A |
3/31/2016 | 5,983 | 1,324 | N/A | 1,296 | N/A |
12/31/2015 | 5,850 | 1,406 | N/A | 1,413 | N/A |
9/30/2015 | 5,654 | 1,392 | N/A | 1,388 | N/A |
6/30/2015 | 5,459 | 1,379 | N/A | 1,364 | N/A |
3/31/2015 | 5,482 | 1,366 | N/A | 1,434 | N/A |
12/31/2014 | 5,505 | 1,354 | N/A | 1,504 | N/A |
9/30/2014 | 5,420 | 1,330 | N/A | 1,432 | N/A |
6/30/2014 | 5,335 | 1,307 | N/A | 1,361 | N/A |
3/31/2014 | 5,189 | 1,270 | N/A | 1,257 | N/A |
12/31/2013 | 5,042 | 1,233 | N/A | 1,154 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSL's forecast earnings growth (13% per year) is above the savings rate (2.6%).
Earnings vs Market: CSL's earnings (13% per year) are forecast to grow faster than the Australian market (12.5% per year).
High Growth Earnings: CSL's earnings are forecast to grow, but not significantly.
Revenue vs Market: CSL's revenue (6.5% per year) is forecast to grow faster than the Australian market (5.8% per year).
High Growth Revenue: CSL's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSL's Return on Equity is forecast to be low in 3 years time (18.6%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 07:22 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CSL Limited is covered by 29 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Russell Wright | Barclay Pearce Capital Pty Limited |
Saul Hadassin | Barrenjoey Markets Pty Limited |
Thomas Wakim | Bell Potter |